Article | July 5, 2024

A Roadmap For Implementing Analytical QbD

Source: ValGenesis
Digital currency-GettyImages-1391690196

Quality by Design (QbD) is a structured approach to pharmaceutical development that starts with predefined objectives. It places a strong emphasis on understanding both the product and the process, alongside rigorous process control. This methodology is grounded in solid scientific principles and incorporates Quality Risk Management (QRM) to ensure comprehensive quality assurance.

Analytical Quality by Design (AQbD) extends these QbD principles specifically to the development of analytical methods. It is a methodical and scientifically driven strategy aimed at creating robust analytical methods by first defining the expected analytical performance outcomes. AQbD relies heavily on the core QbD tools and methodologies, such as Quality Risk Management (QRM), Design of Experiments (DoE), and Multivariate Data Analysis (MVDA), to establish the Method Operable Design Region (MODR). This approach ensures that analytical methods are not only effective but also resilient to variations, ultimately enhancing the reliability and accuracy of the data generated.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online